Pharma channel feed

FDA ax­es di­ag­nos­tic re­quire­ment for Lil­ly's Verzenio + en­docrine ther­a­py in cer­tain breast can­cer pa­tients

3 years ago
FDA+

As­traZeneca, Dai­ichi Sankyo tease new En­her­tu da­ta — but de­tails re­main un­der wraps

3 years ago
R&D

Phar­ma in­dus­try lob­bies Con­gress for so­lu­tion to pri­mate short­age af­ter in­dict­ments for al­leged smug­gling

3 years ago

Lex­i­con dives ‘in­to the dark’ days fol­low­ing heart fail­ure hos­pi­tal­iza­tions with new cam­paign

3 years ago
Marketing

Ac­cel­er­at­ed ap­proval in­com­ing? Mod­er­na 'hope­ful' for per­son­al­ized can­cer vac­cine

3 years ago
FDA+

Es­pe­ri­on un­veils long-await­ed da­ta on cho­les­terol pil­l's abil­i­ty to cut car­dio­vas­cu­lar risk: #ACC23

3 years ago
R&D

FDA is­sues new guid­ance on wet AMD drug de­vel­op­ment

3 years ago
FDA+

Wal­greens de­cides against dis­trib­ut­ing abor­tion pill in some states — re­port

3 years ago
FDA+

Q&A with Chris­tine Baed­er, new chair of the gener­ic in­dus­try’s AAM

3 years ago
FDA+

Re­al Chem­istry in­tends to sync doc­tor and pa­tient mar­ket­ing with physi­cian-fo­cused agency ac­qui­si­tion

3 years ago
Marketing

UK gov­ern­ment plans to hike rev­enue claw­back rates be­gin­ning in April

3 years ago
Financing
Law

Merz Aes­thet­ics hands the mic to Christi­na Aguil­era in Botox ri­val cam­paign

3 years ago
Marketing

J&J’s Janssen calls on co­me­di­an to un­der­score mul­ti­ple myelo­ma in­equities in the Black com­mu­ni­ty

3 years ago
Marketing

Chan Zucker­berg Ini­tia­tive an­nounces Chica­go bio­hub to study tis­sue in­flam­ma­tion

3 years ago
Discovery

Q&A with Ul­tragenyx CEO: Time to in­crease the use of ac­cel­er­at­ed ap­provals for rare dis­ease drugs

3 years ago

House over­sight chair calls for in­ves­ti­ga­tion in­to PBM­s' tac­tics to in­crease drug costs

3 years ago

Pub­li­cis Health aims to sort phar­ma mar­ket­ing da­ta with new ad­vi­so­ry and in­sights busi­ness

3 years ago
Marketing

US spent near­ly $32B in pub­lic funds on mR­NA vac­cine de­vel­op­ment, study finds

3 years ago

Sen­ate health com­mit­tee chair de­mands No­vo, Sanofi drop in­sulin costs af­ter Lil­ly

3 years ago
People

BioN­Tech to ex­pand pres­ence in Is­rael with man­u­fac­tur­ing and re­search site

3 years ago
Manufacturing

FDA sched­ules ad­vi­so­ry com­mit­tee hear­ing for Lyn­parza prostate can­cer ap­pli­ca­tion

3 years ago
FDA+

Ako­rn Phar­ma­ceu­ti­cals files for bank­rupt­cy, clos­es fa­cil­i­ties and will liq­ui­date

3 years ago
People
Manufacturing

FDA adopts ICH guid­ance on con­tin­u­ous man­u­fac­tur­ing

3 years ago
FDA+
Manufacturing

No­vo Nordisk touts ex­pan­sion in Boston, cuts about 100 jobs in two oth­er US cities

3 years ago
R&D
First page Previous page 141142143144145146147 Next page Last page
A service from the Financial Times